Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Vera Bradley, Inc. | ELI | Nov 22, 2024 | 4.98 | +5.06 |
Veracyte, Inc. | 12V | Nov 22, 2024 | 37.00 | 0.00 |
VERALLIA. | 1VRA | Nov 22, 2024 | 25.54 | -1.69 |
Veralto | RZ2 | Nov 22, 2024 | 101.10 | +1.86 |
VERANO HOLDINGS (SUB.VT.) | 76U0 | Nov 22, 2024 | 2.86 | 0.00 |
Verastem | 2VSA | Nov 22, 2024 | 3.66 | +2.81 |
Verbio SE | VBK | Nov 22, 2024 | 10.89 | -1.00 |
Verbrec Limited | 47L | Nov 22, 2024 | 0.06 | 0.00 |
Verbund AG | OEWA | Nov 22, 2024 | 74.65 | +2.26 |
Verbund AG | OEW | Nov 22, 2024 | 14.70 | +2.08 |
Vercom S.A. | 14W | Nov 22, 2024 | 26.20 | 0.00 |
Veren | 0160 | Nov 22, 2024 | 5.05 | -1.66 |
Vergnet | VRQ | Nov 22, 2024 | 0.00 | 0.00 |
Verianos Real Estate AG | VROS | Nov 22, 2024 | 0.00 | 0.00 |
Vericel Corporation | ATQP | Nov 22, 2024 | 53.50 | 0.00 |
Verici Dx Plc | 63V | Nov 22, 2024 | 0.04 | 0.00 |
VerifyMe, Inc. | LT1B | Nov 22, 2024 | 0.66 | -5.76 |
Verimatrix | I3Q | Nov 22, 2024 | 0.31 | -0.64 |
Verint Systems Inc. | VTY | Nov 22, 2024 | 23.20 | +2.65 |
VeriSign, Inc. | VRS | Nov 22, 2024 | 175.60 | +3.32 |
Verisk Analytics, Inc. | VA7A | Nov 22, 2024 | 277.20 | +3.32 |
Veritex Holdings, Inc. | 47Y | Nov 22, 2024 | 27.20 | +2.26 |
Veritone, Inc. | VEK | Nov 22, 2024 | 2.58 | +3.29 |
VERIZON COMMUNICAT. CDR | BACB | Nov 22, 2024 | 12.50 | +2.46 |
Verizon Communications Inc. | BAC | Nov 22, 2024 | 41.56 | +2.38 |
Verkkokauppa.com | 15V | Nov 22, 2024 | 1.38 | -1.29 |
Vermilion Energy Inc. Common (Canada) | CVZ | Nov 22, 2024 | 10.49 | +4.64 |
Verona Pharma plc - American Depositary Shares | I9SA | Nov 22, 2024 | 37.00 | 0.00 |
Verra Mobility Corp | 0YK | Nov 22, 2024 | 22.00 | +1.85 |
Verrica Pharmaceuticals Inc. | 1NE | Nov 22, 2024 | 0.93 | +29.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.